Tuesday, November 29, 2005
Sembiosys plant derived insulin bio-equivalent to human insulin
Sembiosys will publish positive results from their research into the bioequivalance of their recombinant, plant-derived insulin product compared to the equivalent recombinant product produced using traditional techniques.
The plant-derived insulin was expressed in arabidopsis seed. The next step for Sembiosys will be the expression of this product in their commercial expression system, safflower using their Stratosome(TM) Biologics System.
The abstract for the published results is here
|
